Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMPICILLIN vs ANAKINRA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMPICILLIN vs ANAKINRA: Safety Overview

Metric AMPICILLIN ANAKINRA
Total FAERS Reports 3,653 12,145
Deaths Reported 482 979
Death Rate 13.2% 8.1%
Hospitalizations 1,227 3,472
Average Patient Age 45.1 yrs 39.2 yrs
% Female Patients 65.6% 66.3%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Meitheal Pharmaceuticals Inc. Swedish Orphan Biovitrum AB (publ)
Route INTRAVENOUS SUBCUTANEOUS
Marketing Status Discontinued Prescription